Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
McKesson
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Baxter
US Department of Justice

Generated: September 26, 2018

DrugPatentWatch Database Preview

Alfuzosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for alfuzosin hydrochloride and what is the scope of alfuzosin hydrochloride freedom to operate?

Alfuzosin hydrochloride is the generic ingredient in two branded drugs marketed by Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan, Sun Pharma Global, Teva Pharms, Torrent Pharms, Unichem Labs Ltd, Wockhardt Ltd, and Concordia Pharms Inc, and is included in ten NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for alfuzosin hydrochloride. Eighteen suppliers are listed for this compound.

Pharmacology for alfuzosin hydrochloride
Synonyms for alfuzosin hydrochloride
(+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride
133880-44-1
2-Furancarboxamide, N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-, monohydrochloride (+-)-
4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride
403A681
81403-68-1
81403-80-7 (Parent)
AB0008072
AB2000094
AC-1116
AC1L2GRP
AC1Q5PED
AKOS015966770
Alfetim
Alfoten
Alfuzosin (hydrochloride)
Alfuzosin for peak identification, European Pharmacopoeia (EP) Reference Standard
Alfuzosin for system suitability A, European Pharmacopoeia (EP) Reference Standard
Alfuzosin for system suitability, European Pharmacopoeia (EP) Reference Standard
Alfuzosin HCl
Alfuzosin hydrochloride (JAN/USAN)
Alfuzosin hydrochloride (Uroxatral)
Alfuzosin hydrochloride [USAN:USP]
Alfuzosin hydrochloride [USAN]
Alfuzosin hydrochloride, >=98% (HPLC), solid
Alfuzosin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Alfuzosin hydrochloride, pharmaceutical secondary standard; traceable to USP and PhEur
Alfuzosin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Alfuzosin hydrochloride;
API0001407
AS-14240
AT-12271
BC677639
BCP9000271
BCPP000417
C19H27N5O4
C19H28ClN5O4
CAS-81403-68-1
CC-23835
CCG-213373
CHEBI:32286
CHEMBL1723
CS-2087
CTK8F7637
D01692
D0H1YQ
DSSTox_CID_25514
DSSTox_GSID_45514
DSSTox_RID_80924
DTXSID3045514
FT-0630890
HMS1569A05
HY-B0192A
K448
KS-00000XK8
LP00224
LS-70107
MFCD00879135
MolPort-006-391-851
N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride
n-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolynyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride
N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
n-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid
NCGC00016946-01
NCGC00095152-09
NCGC00260909-01
s1409
SCHEMBL179910
SL 77 499-10
SL 77499-10
SL-77.0499-10
SL-77499
SL-77499-10
SL-7749910
Tox21_110701
Tox21_110701_1
Tox21_500224
Urion
Uroxatral
Uroxatral (TN)
Uroxatral hydrochloride
Uroxatral, Alfuzosin hydrochloride
Xatral
Xatral OD
Xatral Retard
Xatral SR
Xatral XL
YTNKWDJILNVLGX-UHFFFAOYSA-N

US Patents and Regulatory Information for alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079056-001 Jul 18, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Concordia Pharms Inc UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharma Global ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079057-001 Jul 18, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apotex Inc ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079013-001 Jul 18, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wockhardt Ltd ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 090221-001 Aug 10, 2012 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 090284-001 Jan 17, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Torrent Pharms ALFUZOSIN HYDROCHLORIDE alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 079054-001 Jul 18, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Concordia Pharms Inc UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for alfuzosin hydrochloride

Country Document Number Estimated Expiration
Australia 724490 ➤ Try a Free Trial
Japan 3797388 ➤ Try a Free Trial
Norway 326206 ➤ Try a Free Trial
Portugal 938318 ➤ Try a Free Trial
New Zealand 334018 ➤ Try a Free Trial
Colombia 4920217 ➤ Try a Free Trial
South Korea 100364328 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Citi
McKesson
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Daiichi Sankyo
Baxter
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.